Physician profile
Brianna Cook
NPI 1396588943
$1,929.98
in general payments reported to CMS, 2019-2025
14 companies · $1,395 in 2025
The $1,395 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $535 · 2025: $1,395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,929.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $450.56 | 2024-2025 | |
| Calliditas Therapeutics US INC. | $381.37 | 2024-2025 | Tarpeyo |
| Astrazeneca Pharmaceuticals LP | $330.13 | 2024-2025 | Farxiga, Lokelma |
| Otsuka America Pharmaceutical, INC. | $253.38 | 2024-2025 | Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $123.22 | 2024-2025 | |
| Akebia Therapeutics INC | $109.89 | 2024-2025 | Vafseo |
| Ardelyx, INC. | $50.98 | 2024-2025 | Ibsrela |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.32 | 2024-2025 | Jardiance |
| Vifor Pharma, INC. | $44.97 | 2024-2025 | Veltassa |
| Novartis Pharmaceuticals Corporation | $34.38 | 2025 | |
| Lilly USA, LLC | $34.09 | 2025 | Jardiance |
| Cycle Pharmaceuticals INC | $27.49 | 2025 | Venxxiva |
| Ani Pharmaceuticals, INC. | $22.50 | 2025 | Purified Cortrophin Gel |
| Amgen INC. | $16.70 | 2025 | Tavneos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brianna Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.